Decision details
FP10 Recharges – Public Health Primary Care Medication Costs
Decision Maker: Director Public Health
Decision status: Recommendations Approved
Is Key decision?: No
Is subject to call in?: No
Purpose:
As of April 2013, Local Authorities have
responsibility for commissioning public health services as part of
their duty to take steps to improve the health of people in their
area. Public Health grant allocations made to Local Authorities are
therefore designed to reflect the full costs of commissioning
public health services, including any necessary costs relating to
the prescribing of medications relevant to public health
services.
Some Public Health services will involve the supply of medicines
and appliances using NHS pharmacy services - these include:
substance misuse, smoking cessation support and sexual health
services, each of which involves the prescription of medications to
service users.
Whilst the majority of medication costs are included within
specialist Public Health commissioned service budgets, there will
be some instances where individuals can only access certain
medications outside of commissioned services (e.g. prescription
only smoking medications); or where individuals choose to access
support from their local primary care GP. Furthermore, there is a
duty to ensure individuals can access support as widely as possible
including via primary care sites.
Prescribing of public health relevant medications for patients in
primary care settings will often occur on FP10 prescription forms
which can be taken by the patient to a community pharmacist for
dispensing. The use of these prescription forms allows patients to
choose which pharmacy they obtain their medication from
Whilst the responsibility and funding for these public health
services lies with Sandwell Public Health, costs associated with
primary care prescribing of public health relevant medications are
borne by Black Country Integrated Care Board (formerly Sandwell
& West Birmingham Clinical Commissioning Group). These costs
relate to payments to the community pharmacy where a prescription
is dispensed and the cost of the prescription drugs themselves. As
such, it is necessary to reimburse Black Country ICB for costs
incurred due to public health medications.
Criteria that will be used to determine which medication costs will
be reimbursed by Public Health are as follows:
• All drug and alcohol medication costs will be
reimbursed
• Orlistat for obesity will not be reimbursed as it is a tier
3 weight management service which doesn’t fall within the
remit of public health commissioned services.
• Emergency hormonal contraception costs will not be
reimbursed as they are covered by the primary care GP contract.
However, long acting contraceptive devices and appliances are not
covered by this and are reimbursed by public health.
• Nicotine replacement therapy is not reimbursed as this is
already purchased through the Public Health procured smoking
cessation service. The cost of smoking related prescription only
medications (e.g. Bupropion, Varenicline) will be reimbursed from
the Public Health budget.
• Any of the above outlined costs in relation to primary care
practices outside of the Sandwell borough border will not be
reimbursed
Quarterly costs are routinely scrutinised for monitoring purposes
and to ensure claims made are in line with the agreed criteria for
reimbursement outlined in the paragraph and bullet points
above.
Decision:
(1) That the Director of Public Health approve
to reimburse FP10 Public Health medication costs to the Black
Country Integrated Care Board up to a maximum of £500,000
covering a period until 31st March 2034.
(2) That should the organisation administrating and managing the
FP10 recharges change constitution or name, approval for the
Director of Public Health to authorise and continue payment to any
subsequently changed organisation /body who would continue to
manage this element
Reasons for the decision:
Payment in relation to FP10 Public Health
medication costs is not currently possible given the administrating
body has changed from Sandwell & West Birmingham Clinical
Commissioning Group (CCG) to Black Country Integrated Care Board
(ICB). Existing approval related to these payments no longer stands
as it explicitly stated that the reimbursement is to go to Sandwell
& West Birmingham CCG (which no longer exists) and there is no
provision within the existing approval for the Director to
authorise payment to a different/subsequent body. There are
therefore now outstanding invoices in need of payment.
Previous approval was secured for the Director of Public Health to
make FP10 payments to the Sandwell & West Birmingham CCG
covering the period until 31st March 2025 (see Appendix 1 previous
approval report). It has now become necessary to revisit this
agreement prior to the approved end date given the change in
organisational name/constitution, and as part of this revisit to
extend the period of payment in line with Director level approval
limits up to a maximum of £500,000 covering the period until
31st March 2034 (annual charges approximately £40,000 to
£50,000 per annum).
Alternative options considered:
To not approve the reimbursement of Public
Health related primary care medications. This would be contrary to
the terms of the Public Health grant and would require that such
costs be borne by the Black Country IBC instead who may not agree
to this, and ultimately impact access to important
medications.
An alternative option is for Sandwell Public Health to administrate
and manage the scheme directly with the primary care providers.
This option however would require additional staff to manage and
administrate such an arrangement and it would create two schemes
requiring GPs to retrieve funding from two different commissioners
(the Council and the Black Country ICB) which would add complexity
and deter engagement and the provision of public health services
would be adversely impacted.
Publication date: 08/01/2024
Date of decision: 30/11/2023